ImmunoGen announced that Isabel Kalofonos has been appointed Senior Vice President and Chief Commercial Officer. Kalofonos joins ImmunoGen from Galderma, where she served as Senior Vice President and Global Head of the Prescription Business Unit.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IMGN:
- JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
- Sutro transferred with Equal Weight from Overweight at Wells Fargo
- Immunogen confident in early Elahere launch, says Guggenheim
- ImmunoGen sees FY23 revenue $30M-$35M, consensus $117.67M
- ImmunoGen reports Q4 EPS (23c), consensus (30c)